ロード中...
Sulfasalazine for treating rheumatoid arthritis
BACKGROUND: Sulfasalazine has become a common second line drug (DMARD) for the treatment of rheumatoid arthritis (RA). OBJECTIVES: To estimate the short‐term efficacy and toxicity of sulfasalazine for the treatment of rheumatoid arthritis (RA). SEARCH METHODS: We searched the Cochrane Musculoskeleta...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
1998
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047550/ https://ncbi.nlm.nih.gov/pubmed/10796400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000958 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|